InsidersTradesSigma
Explore the complete record of transactions filed by Tsai Benjamin, Director. Officer active across 2 companies, notably Oyster Point Pharma, Inc.. Aggregated, 3 reports have been logged. The latest transaction was filed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Benjamin Tsai is a Board Member at Oyster Point Pharma, Inc. He plays a key role in overseeing the company's activities and strategic direction. His experience in the pharmaceutical sector allows him to provide valuable insights to the board.